Earnings call briefFiscal first-quarter 2027
Medtronic raises fiscal 2027 organic revenue growth outlook to 7.25% to 7.75%
Medtronic also said it expects fiscal second-quarter EPS of $1.32 to $1.34 and fiscal 2027 EPS of $5.94 to $6.
GetSignal Medtronic MDT
Medtronic said on its fiscal first-quarter call that it now expects fiscal 2027 organic revenue growth of 7.25% to 7.75%, up 50 basis points from its prior guidance. It expects fiscal 2027 operating profit to grow approximately 10%.
Chief Financial Officer Thierry Pieton said the company has included in its EPS guidance the foregone interest on a $700 million investment in Cornerstone Robotics.
Quotes from the call
“Given the strength in the first quarter, we're also raising our fiscal '27 guidance range to $5.94 to $6.”
Key facts from the call
- Fiscal 2027 organic revenue growth outlook
- 7.25% to 7.75%
- Fiscal 2027 EPS outlook
- $5.94 to $6
- Fiscal second-quarter EPS outlook
- $1.32 to $1.34
Source: Medtronic's fiscal first-quarter 2027 earnings call, September 1, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
- TeraWulf sees about half of contracted IT capacity earning revenue by end of Q1
WULF TeraWulf Q3 2026 call
